Neuropharmacological Regulation of Episodic Growth Hormone and Prolactin Secretion in the Rat

Publisher Website
Google Scholar
Abstract
The effects on GH [growth hormone] and PRL [prolactin] secretion of several pharmacological agents known to modify central neurotransmitter action were determined in unanesthetized male rats. Phenoxybenzamine, an .alpha.-adrenergic blocker (5 mg/kg i.v.), abolished episodic GH secretion and caused elevation of serum PRL levels. Propranolol, a .beta.-adrenergic blocker (5 mg/kg i.v.), had no effect on GH secretion and caused a small but significant depression in PRL levels. p-Chlorophenylalanine methyl ester, an inhibitor of tryptophan hydroxylase (300-350 mg/kg i.p.), resulted in significant inhibition of GH pulsatile secretion and suppressed PRL levels. Methysergide hydrogen maleinate (25 mg/kg i.v.), a serotonin receptor antagonist, also inhibited GH secretion, but produced a transient stimulation in PRL levels. Atropine sulfate (2 mg/kg i.v.) caused significant suppression in GH secretion, but had no effect on PRL. Picrotoxin, a .gamma.-aminobutyric acid antagonist, in a subconvulsive dose of 1-3 mg/kg i.v. also depressed GH episodic secretion but did not affect PRL levels. These results indicate that several neurotransmitters, i.e., norepinephrine, serotonin, acetylcholine and GABA, found in high concentration in the hypothalamus, influence GH and PRL secretion.